Skip to content

Clinical trials

Phase 2 Liver Failure trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Failure Phase: Phase 2 Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20081
20092
20102
20111
20121
20132
20141
20151
20161
20211
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated6
Unknown status6
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University4
Azienda Ospedaliera di Padova2
Veloxis Pharmaceuticals2
All India Institute of Medical Sciences1
Conatus Pharmaceuticals Inc.1
Genfit1
Insel Gruppe AG, University Hospital Bern1
Louisiana State University Health Sciences Center in New Orleans1
Mylan Specialty, LP1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Failure21
Liver Diseases5
Fibrosis4
Liver Failure, Acute4
Acute-On-Chronic Liver Failure2
Carcinoma, Hepatocellular2
Hepatic Encephalopathy2
Liver Cirrhosis2
Liver Neoplasms2
Ascites1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.